DoctorAdam vs BetterMe Rx
Neither of these prices is a ceiling: one climbs with every dose step, and the other is a discount under a clock that restarts every three days.
DoctorAdam
Editorial
$199/mo
Semaglutide opens at $129 a month in either form and tirzepatide at $229 by injection, with the price stated to cover evaluation, prescription, medication and shipping, and no membership. Those are opening figures: dosage moves them, the strengths run from 0.22mg to 2.2mg, and no per-strength price is published.
- Milligram strengths are published for the semaglutide injection
- The price covers evaluation, prescription, medication and shipping
- No membership or program fee is charged alongside the medication
- Brand Wegovy and Foundayo are sold beside the compounded lines
- Prices scale with dose and no per-strength figure is published
- The FAQ's $199 floor sits above the $129 on two product cards
- Compounding pharmacies are not named
- The plan screen is behind a name field at step two of the intake
Pick it for: Starting low, if you can wait to learn the rungs
Not for: Anyone pricing a maintenance dose before signing up.
BetterMe Rx
Editorial
$265/mo
The compounded semaglutide injection is $199 a month, under a struck-through anchor and a countdown that carries no end date and restarts every three days. Medication, provider review, compounding, supplies and shipping are stated to be included, and no membership is charged.
- Medication, provider review, supplies and shipping are stated to be included
- No membership or program fee sits outside the plan price
- Both molecules are offered as a tablet as well as an injection
- The plan length behind each low figure is printed on the card
- The countdown framing the intro price restarts on a three-day loop
- The struck-through reference price does not establish the charge for a selected plan
- The $99 headline requires a twelve-month commitment
- The compounding pharmacy is not named
Pick it for: Ignoring the sale framing and judging the figure itself
Not for: Anyone relying on a countdown without checking the actual plan terms.
Our verdict
DoctorAdam's price moves with dose, and the strengths it publishes are its semaglutide ones — the tablet ladder sits behind a name field at step two of a nineteen-step intake, so the rung you will actually settle on is unpriced. BetterMe Rx displays a discounted figure beside a struck-through reference price. The recorded countdown restarts on a three-day window without a fixed end date; that observation does not establish what every customer pays. Compare the offered plan's charge, term and renewal rather than treating the timer as evidence that a deadline requires an immediate purchase.
What actually separates them
DoctorAdam and BetterMe Rx differ on published price and states a milligram dose. The table summarizes those terms; confirm any details it does not cover with the provider.
BetterMe Rx’s comparison figure is $66 higher than DoctorAdam’s — a 33% difference between the listed rates. These figures do not establish equivalent prescribed doses, supply or care. Confirm the selected product, full payment obligation and next charge.
At unchanged rates, a twelve-month illustration is about $2,388 at DoctorAdam against $3,180 at BetterMe Rx — a difference of $792. This is not a quote for a year of care: actual charges depend on prescribed supply, purchase terms and renewals.
| DoctorAdam | BetterMe Rx | |
|---|---|---|
| Published price | $199/mo | $265/mo |
| States a milligram dose | Yes | No |
What neither of them tells you
A comparison that only reports differences implies everything else is settled. Here it is not.
- Both sell a compounded drug and neither names the pharmacy that compounds it.
Before you choose either
The providers describe different service areas. BetterMe Rx lists 6 that DoctorAdam does not list — AK, MA, MS, NJ, RI, VT. Confirm your location and selected medication directly. A provider-wide footprint does not establish every treatment’s availability.
Only one of these two publishes a milligram dose, which makes a straight price comparison impossible: you can tell what each costs, but only one tells you what you get. Ask the other what dose its price buys before you commit, then set both numbers against every published price we hold. A seller that will not answer that question has told you something.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.